Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Feb:117:28-35.
doi: 10.1016/j.plefa.2017.01.007. Epub 2017 Jan 25.

Effects of a lipid-based nutrient supplement during pregnancy and lactation on maternal plasma fatty acid status and lipid profile: Results of two randomized controlled trials

Affiliations
Randomized Controlled Trial

Effects of a lipid-based nutrient supplement during pregnancy and lactation on maternal plasma fatty acid status and lipid profile: Results of two randomized controlled trials

Brietta M Oaks et al. Prostaglandins Leukot Essent Fatty Acids. 2017 Feb.

Abstract

It is unknown whether a novel small-quantity lipid-based nutrient supplement (SQ-LNS) containing alpha-linolenic (ALA) and linoleic acids impacts maternal plasma lipids and fatty acid status. We measured plasma fatty acids (wt%) and lipid concentrations at 36 wk gestation and breast milk fatty acids (wt%) at 6 months postpartum in a subsample of women enrolled in a randomized controlled trial studying the effects of SQ-LNS on birth outcomes and child growth. Women≤20 wk gestation in Ghana (n=1,320) and Malawi (n=1,391) were assigned to receive daily either: 1) iron-folic acid (pregnancy); 2) multiple micronutrients (pregnancy and lactation); or 3) SQ-LNS (pregnancy and lactation). At 36 wk, plasma ALA levels were higher in those receiving SQ-LNS. SQ-LNS increased breast milk ALA in Ghana but not Malawi. There was no effect on plasma lipids or other selected fatty acids. SQ-LNS may impact plasma and breast milk ALA levels depending on the population.

Trial registration: ClinicalTrials.gov NCT00970866 NCT01239693.

Keywords: Cholesterol; Lactation; Lipids; Omega-3 fatty acids; Pregnancy; Supplementation.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1
Fatty acid profile of maternal plasma at enrollment and 36 wk gestation and breast milk at 6 mo postpartum.
Fig. 2.
Fig. 2
‘Other’ fatty acids category from Fig. 1 expanded.

References

    1. Lauritzen L., Carlson S.E. Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status. Matern. Child Nutr. 2011;7:41–58. - PMC - PubMed
    1. Greenberg J.A., Bell S.J., Ausdal W.V. Omega-3 fatty acid supplementation during pregnancy. Rev. Obstet. Gynecol. 2008;1:162–169. - PMC - PubMed
    1. Burdge G.C., Wootton S.A. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br. J. Nutr. 2002;88:411–420. - PubMed
    1. Del Gobbo L.C., Imamura F., Aslibekyan S., Marklund M., Virtanen J.K., Wennberg M., Yakoob M.Y., Chiuve S.E., Dela Cruz L., Frazier-Wood A.C., Fretts A.M., Guallar E., Matsumoto C., Prem K., Tanaka T., Wu J.H., Zhou X., Helmer C., Ingelsson E., Yuan J.M., Barberger-Gateau P., Campos H., Chaves P.H., Djousse L., Giles G.G., Gomez-Aracena J., Hodge A.M., Hu F.B., Jansson J.H., Johansson I., Khaw K.T., Koh W.P., Lemaitre R.N., Lind L., Luben R.N., Rimm E.B., Riserus U., Samieri C., Franks P.W., Siscovick D.S., Stampfer M., Steffen L.M., Steffen B.T., Tsai M.Y., van Dam R.M., Voutilainen S., Willett W.C., Woodward M., Mozaffarian D. omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies. JAMA Intern. Med. 2016;176:1155–1166. - PMC - PubMed
    1. Pan A., Chen M., Chowdhury R., Wu J.H., Sun Q., Campos H., Mozaffarian D., Hu F.B. alpha-linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am. J. Clin. Nutr. 2012;96:1262–1273. - PMC - PubMed

Publication types

MeSH terms

Associated data